Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
85.7M
-
Shares change
-
-6.78M
-
Total reported value, excl. options
-
$66.3M
-
Value change
-
-$8.85M
-
Put/Call ratio
-
12.85
-
Number of buys
-
43
-
Number of sells
-
-50
-
Price
-
$0.77
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q1 2024
130 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q1 2024.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.7M shares
of 170M outstanding shares and own 50.29% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), FMR LLC (22.7M shares), BlackRock Inc. (6.83M shares), VANGUARD GROUP INC (6.73M shares), Hudson Bay Capital Management LP (5.43M shares), GEODE CAPITAL MANAGEMENT, LLC (2.13M shares), Woodline Partners LP (2.05M shares), STATE STREET CORP (1.95M shares), BANK OF AMERICA CORP /DE/ (1.65M shares), and Eversept Partners, LP (1.39M shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.